Name
Community Pharmacists and Harm Reduction: Evidence and Opportunities
Date & Time
Tuesday, April 3, 2018, 2:00 PM - 3:15 PM
Speakers
Nicholas Hagemeier, PharmD, PhD, Associate Professor and Research Director, Gatton College of Pharmacy, East Tennessee State University
KariLynn Dowling, PharmD, Community Pharmacy Practice Research Fellow, Gatton College of Pharmacy, East Tennessee State University
KariLynn Dowling, PharmD, Community Pharmacy Practice Research Fellow, Gatton College of Pharmacy, East Tennessee State University
Description
Moderator: Anne L. Burns, RPh, Vice President, Professional Affairs, American Pharmacists Association, and Member, National Rx Drug Abuse & Heroin Summit Advisory Board
CE Certified By: AMA,AAFP,ACPE,ANCC,NAADAC,NASW,NBCC
Harm reduction is a concept that has gained momentum as it relates to prevention of negative consequences of drug use. Some harm reduction approaches, such as naloxone provision, have garnered significant support, whereas others, such as providing access to clean syringes, are the exception as opposed the rule. Evidence suggests there is significant variation in harm reduction behaviors among providers, including community pharmacists. Community pharmacies are one of the most accessible points for healthcare; approximately 90% of U.S. residents live within five miles of a pharmacy. Therefore, pharmacies have a great opportunity to promote and engage their communities in harm reduction approaches.
This session will examine evidence-based harm reduction approaches that can be employed in community pharmacies. The presenters will use their syringe dispensing research conducted across three states to describe the current harm reduction climate in community pharmacies. During this interactive session, participants will discuss scenarios in which they are encouraged to evaluate their own attitudes and beliefs toward non-Rx syringe sales, naloxone dispensing and other harm reduction strategies while taking a look at the impact of state level policies on these approaches. The session will be targeted to practicing pharmacists, coalition leaders and harm reduction stakeholders.
UPON COMPLETION OF THIS COURSE, PARTICIPANTS WILL BE ABLE TO:
- Explain harm reduction approaches that can be implemented in community pharmacy settings.
- Describe the perceptions and behaviors of pharmacists related to non-Rx syringe sales and other harm reduction approaches.
- Evaluate the feasibility of implementing harm reduction approaches in a pharmacy and/or partnering with one or more community pharmacies to engage in harm reduction approaches.
CE Certified By: AMA,AAFP,ACPE,ANCC,NAADAC,NASW,NBCC
Harm reduction is a concept that has gained momentum as it relates to prevention of negative consequences of drug use. Some harm reduction approaches, such as naloxone provision, have garnered significant support, whereas others, such as providing access to clean syringes, are the exception as opposed the rule. Evidence suggests there is significant variation in harm reduction behaviors among providers, including community pharmacists. Community pharmacies are one of the most accessible points for healthcare; approximately 90% of U.S. residents live within five miles of a pharmacy. Therefore, pharmacies have a great opportunity to promote and engage their communities in harm reduction approaches.
This session will examine evidence-based harm reduction approaches that can be employed in community pharmacies. The presenters will use their syringe dispensing research conducted across three states to describe the current harm reduction climate in community pharmacies. During this interactive session, participants will discuss scenarios in which they are encouraged to evaluate their own attitudes and beliefs toward non-Rx syringe sales, naloxone dispensing and other harm reduction strategies while taking a look at the impact of state level policies on these approaches. The session will be targeted to practicing pharmacists, coalition leaders and harm reduction stakeholders.
UPON COMPLETION OF THIS COURSE, PARTICIPANTS WILL BE ABLE TO:
- Explain harm reduction approaches that can be implemented in community pharmacy settings.
- Describe the perceptions and behaviors of pharmacists related to non-Rx syringe sales and other harm reduction approaches.
- Evaluate the feasibility of implementing harm reduction approaches in a pharmacy and/or partnering with one or more community pharmacies to engage in harm reduction approaches.
Location Name
Baker
Full Address
Hyatt Regency Atlanta
265 Peachtree St NE
Atlanta, Georgia 30303
United States
265 Peachtree St NE
Atlanta, Georgia 30303
United States